Skip to content
Medium cut-off hemodialysis in multiple myeloma-associated cast nephropathy: A single-center experience
All contributors

Onconephrology contributor

Johnson, Richard J

Primarily Tumor lysis & electrolytes#40 of 47 recognized
  • #1 in Tumor lysis & electrolytes
6
Clinical papers
851
Citations (iCite)
2 / 3
First / senior author
2012–2018
Active years

Output over time

Clinical corpus papers per year — peak 2 in 2016.

  • 2012: 1 paper
  • 2014: 1 paper
  • 2016: 2 papers
  • 2017: 1 paper
  • 2018: 1 paper
20122018

Subfield mix

Clinical papers by onconephrology subfield (a paper can count in more than one).

Tumor lysis & electrolytes5
Anticancer drug nephrotoxicity1

Verify

Representative recent papers, and this author’s full PubMed bibliography.

PMID 29496260 (opens PubMed in a new tab)PMID 28407135 (opens PubMed in a new tab)PMID 27548821 (opens PubMed in a new tab)PMID 26766409 (opens PubMed in a new tab)PMID 24550457 (opens PubMed in a new tab)PMID 22503466 (opens PubMed in a new tab)All papers on PubMed

A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.